Your browser doesn't support javascript.
loading
Synthesis and in silico evaluation of novel compounds for PET-based investigations of the norepinephrine transporter.
Neudorfer, Catharina; Seddik, Amir; Shanab, Karem; Jurik, Andreas; Rami-Mark, Christina; Holzer, Wolfgang; Ecker, Gerhard; Mitterhauser, Markus; Wadsak, Wolfgang; Spreitzer, Helmut.
Afiliación
  • Neudorfer C; Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. catharina.neudorfer@gmail.com.
  • Seddik A; Division of Drug Design and Medicinal Chemistry, Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. amir.seddik@univie.ac.at.
  • Shanab K; Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. wolfgang.holzer@univie.ac.at.
  • Jurik A; Division of Drug Design and Medicinal Chemistry, Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. andreas.jurik@univie.ac.at.
  • Rami-Mark C; Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
  • Holzer W; Division of Drug Synthesis, Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. wolfgang.holzer@univie.ac.at.
  • Ecker G; Division of Drug Design and Medicinal Chemistry, Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. gerhard.f.ecker@univie.ac.at.
  • Mitterhauser M; Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. markus.mitterhauser@meduniwien.ac.at.
  • Wadsak W; Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. wolfgang.wadsak@meduniwien.ac.at.
  • Spreitzer H; Division of Drug Synthesis, Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstraße 14, 1090 Vienna, Austria. helmut.spreitzer@univie.ac.at.
Molecules ; 20(1): 1712-30, 2015 Jan 20.
Article en En | MEDLINE | ID: mdl-25608857
ABSTRACT
Since the norepinephrine transporter (NET) is involved in a variety of diseases, the investigation of underlying dysregulation-mechanisms of the norepinephrine (NE) system is of major interest. Based on the previously described highly potent and selective NET ligand 1-(3-(methylamino)-1-phenylpropyl)-3-phenyl-1,3-dihydro-2H-benzimidaz- ol-2-one (Me@APPI), this paper aims at the development of several fluorinated methylamine-based analogs of this compound. The newly synthesized compounds were computationally evaluated for their interactions with the monoamine transporters and represent reference compounds for PET-based investigation of the NET.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Simulación por Computador / Radiofármacos / Tomografía de Emisión de Positrones / Proteínas de Transporte de Noradrenalina a través de la Membrana Plasmática Límite: Humans Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Simulación por Computador / Radiofármacos / Tomografía de Emisión de Positrones / Proteínas de Transporte de Noradrenalina a través de la Membrana Plasmática Límite: Humans Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Austria